Rachel Cervantes
About Rachel Cervantes
Rachel Cervantes, Ph.D., is the Vice President of Business Development with a strong background in molecular biology and business, holding degrees from the University of Cincinnati and the Wharton School.
Vice President of Business Development
Rachel Cervantes, Ph.D., currently holds the title of Vice President of Business Development. In this role, she is responsible for leading strategic growth initiatives, managing business partnerships, and driving market expansion efforts. Her work involves analyzing market trends, identifying new opportunities, and collaborating with cross-functional teams to achieve business objectives.
Educational Background
Rachel Cervantes earned a Ph.D. in molecular biology from the University of Cincinnati. She also holds an MBA from the Wharton School, enhancing her understanding of business strategies and financial management. Additionally, she completed a B.A. from the University of Hawai’i at Manoa, providing her with a strong foundation in her academic and professional journey.
Career at Leading Pharmaceutical Companies
Rachel Cervantes has a rich professional background, having worked at several prominent pharmaceutical companies. At GW Pharmaceuticals, Synthetic Genomics, Egalet Corporation, and Inovio Pharmaceuticals, she held various roles that contributed to her expertise in the field. These experiences allowed her to develop a comprehensive understanding of the pharmaceutical industry and its market dynamics.
Early Career at Merck
Rachel Cervantes began her career at Merck, where she gained valuable experience in project and portfolio management, marketing, and business development. These roles allowed her to develop her skills in managing large-scale projects, understanding market needs, and driving business growth. Her early career at Merck laid the foundation for her subsequent success in the pharmaceutical industry.